Inventis launches Celesta: a cutting-edge clinical system for auditory and vestibular evoked potentials
Inventis, a leading innovator in audiology and balance diagnostic solutions, is proud to announce the launch of Celesta, a next-generation 2-channels system designed for comprehensive auditory and vestibular evoked potentials testing. Offering unparalleled flexibility and scalability, Celesta is an advanced solution that meets the diverse needs of clinicians in a wide range of medical settings.
Celesta is designed to improve clinical workflows and elevate diagnostic precision through its seamless integration with Maestro, the all-in-one software platform exclusively developed by Inventis. This integration ensures unified management of all Inventis devices, delivering unparalleled efficiency and adaptability for clinicians conducting advanced testing procedures.
The Celesta system is designed with a highly scalable, modular approach, enabling users to configure it based on their specific needs. Whether for a small clinic or a large hospital network, Celesta offers robust features tailored to auditory and vestibular testing, including ABR, eABR, ECochG, MLR, LLR, and both cervical and ocular VEMP tests. Additionally, the system is set to include the HEARLab ACA (Aided Cortical Assessment), currently under implementation, further expanding its diagnostic capabilities.
Celesta is equipped with advanced smart features to streamline clinical workflows and enhance efficiency, speed and ease of use. From its automatic single-channel switch and guided electrode connection with LED indicators, to software-based electrode configuration and dedicated cervical and ocular VEMP tests, Celesta simplifies setup and ensures precise, high-quality diagnostic results across various applications.
"Celesta marks our company's entry into the evoked potentials segment, a key step in our growth strategy" says Massimo Martinelli, General Manager of Inventis. "Celesta fully embodies the Inventis DNA. Extreme ease of setup and use, flexibility in configuration, full integration with our Maestro software suite, smartness, accessibility: these are features shared by all the instruments in our orchestra, with the sole aim of improving patient care."
Celesta is now available for pre-order (first deliveries at the beginning of 2025).
For more information about the device, click here.